| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |